BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15148503)

  • 1. Gliosarcoma with epithelial differentiation: immunohistochemical and molecular characterization. A case report and review of the literature.
    Ozolek JA; Finkelstein SD; Couce ME
    Mod Pathol; 2004 Jun; 17(6):739-45. PubMed ID: 15148503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
    Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
    Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gliosarcoma: an immunohistochemical, ultrastructural and fluorescence in situ hybridization study.
    Horiguchi H; Hirose T; Kannuki S; Nagahiro S; Sano T
    Pathol Int; 1998 Aug; 48(8):595-602. PubMed ID: 9736406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma.
    Zainuddin N; Jaafart H; Isa MN; Abdullah JM
    Neurol Res; 2004 Jan; 26(1):88-92. PubMed ID: 14977064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype versus genotype in gliomas displaying inter- or intratumoral histological heterogeneity.
    Walker C; du Plessis DG; Joyce KA; Machell Y; Thomson-Hehir J; Al Haddad SA; Broome JC; Warnke PC
    Clin Cancer Res; 2003 Oct; 9(13):4841-51. PubMed ID: 14581356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.
    Cairncross JG; Ueki K; Zlatescu MC; Lisle DK; Finkelstein DM; Hammond RR; Silver JS; Stark PC; Macdonald DR; Ino Y; Ramsay DA; Louis DN
    J Natl Cancer Inst; 1998 Oct; 90(19):1473-9. PubMed ID: 9776413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1p19q LOH patterns and expression of p53 and Olig2 in gliomas: relation with histological types and prognosis.
    Durand KS; Guillaudeau A; Weinbreck N; DeArmas R; Robert S; Chaunavel A; Pommepuy I; Bourthoumieu S; Caire F; Sturtz FG; Labrousse FJ
    Mod Pathol; 2010 Apr; 23(4):619-28. PubMed ID: 20081802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
    Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic alterations in glioblastomas with oligodendroglial component.
    Kraus JA; Lamszus K; Glesmann N; Beck M; Wolter M; Sabel M; Krex D; Klockgether T; Reifenberger G; Schlegel U
    Acta Neuropathol; 2001 Apr; 101(4):311-20. PubMed ID: 11355302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.
    Cachia D; Kamiya-Matsuoka C; Mandel JJ; Olar A; Cykowski MD; Armstrong TS; Fuller GN; Gilbert MR; De Groot JF
    J Neurooncol; 2015 Nov; 125(2):401-10. PubMed ID: 26354773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gliosarcoma arising from oligodendroglioma (Oligosarcoma): A case report with genetic analyses.
    Tanaka S; Hitotsumatsu T; Sugita Y; Ishido K; Ito O; Hatae R; Akagi Y; Yoshimoto K; Iihara K
    Pathol Int; 2018 Oct; 68(10):567-573. PubMed ID: 30246385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of the STOML3, FREM2, and LHFP genes is associated with mesenchymal differentiation in gliosarcoma.
    Nagaishi M; Kim YH; Mittelbronn M; Giangaspero F; Paulus W; Brokinkel B; Vital A; Tanaka Y; Nakazato Y; Legras-Lachuer C; Lachuer J; Ohgaki H
    Am J Pathol; 2012 May; 180(5):1816-23. PubMed ID: 22538188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T
    Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gliosarcoma with chondroid and osseous differentiation.
    Schittenhelm J; Erdmann T; Maennlin S; Will BE; Beschorner R; Bornemann A; Meyermann R; Mittelbronn M
    Neuropathology; 2007 Feb; 27(1):90-4. PubMed ID: 17319288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 9p and 10q losses predict unfavorable outcome in low-grade gliomas.
    Houillier C; Mokhtari K; Carpentier C; Crinière E; Marie Y; Rousseau A; Kaloshi G; Dehais C; Laffaire J; Laigle-Donadey F; Hoang-Xuan K; Sanson M; Delattre JY
    Neuro Oncol; 2010 Jan; 12(1):2-6. PubMed ID: 20150361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry.
    Sreenan JJ; Prayson RA
    Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional factors for epithelial-mesenchymal transition are associated with mesenchymal differentiation in gliosarcoma.
    Nagaishi M; Paulus W; Brokinkel B; Vital A; Tanaka Y; Nakazato Y; Giangaspero F; Ohgaki H
    Brain Pathol; 2012 Sep; 22(5):670-6. PubMed ID: 22288519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of 1p, 19q, 9p and 10q Automated Analysis by FISH to the Diagnosis and Prognosis of Oligodendroglial Tumors According to WHO 2016 Guidelines.
    Michaud K; de Tayrac M; D'Astous M; Duval C; Paquet C; Samassekou O; Gould PV; Saikali S
    PLoS One; 2016; 11(12):e0168728. PubMed ID: 28030632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcomatous evolution of oligodendroglioma ("oligosarcoma"): confirmatory report of an uncommon pattern of malignant progression in oligodendroglial tumors.
    Vajtai I; Vassella E; Hewer E; Kappeler A; Reinert MM
    Pathol Res Pract; 2012 Dec; 208(12):750-5. PubMed ID: 23102810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.